What is the best treatment for a chronic onychomycosis of the second toenail that has been present for one year in a female patient?

Best Treatment for Chronic Toenail Onychomycosis

For a toenail onychomycosis present for one year, oral terbinafine 250 mg daily for 12-16 weeks is the best treatment option, but only after obtaining mycological confirmation of fungal infection. 1

Critical First Step: Confirm the Diagnosis

Before starting any treatment, you must obtain mycological confirmation through:

• Potassium hydroxide (KOH) preparation with microscopy
• Fungal culture (to identify the specific organism)
• Or molecular testing (PCR)

Do not treat based on clinical appearance alone - approximately 50% of nail dystrophies are NOT fungal infections 2, 3. Starting systemic antifungals without confirmation wastes time, money, and exposes the patient to unnecessary risks.

Treatment Algorithm Based on Confirmed Dermatophyte Infection

First-Line: Oral Terbinafine

• Dosing: 250 mg daily for 12-16 weeks for toenails 1
• Efficacy: 55% complete cure rate (mycological clearance + normal nail appearance) at 72 weeks 1
• Long-term success: 46% remain cured at 5 years without retreatment 1
• Relapse rate: Only 23% compared to 53% with itraconazole 1

Why terbinafine is superior: Multiple large studies consistently demonstrate terbinafine outperforms itraconazole both in vitro and in vivo, with higher cure rates, lower relapse rates, and fewer drug interactions 2, 1.

Second-Line: Oral Itraconazole

Use if terbinafine is contraindicated or not tolerated:

• Continuous dosing: 200 mg daily for 12 weeks 1
• Pulse dosing: 400 mg daily for 1 week per month × 3 pulses for toenails 1
• Efficacy: 26% complete cure rate (significantly lower than terbinafine) 1

Topical Therapy Alone - Limited Role

Topical antifungals are inferior to systemic therapy and should only be used when:

• Less than 20% of nail plate affected
• No lunula involvement
• Distal disease only
• Systemic therapy contraindicated 1

Options include:

• Amorolfine 5% lacquer weekly for 6-12 months (50% efficacy) 1
• Efinaconazole 10% daily for 48 weeks (50% mycological cure, 15% complete cure) 1

Important Safety Considerations

Before Starting Terbinafine:

• Baseline liver function tests and complete blood count if patient has:
  • History of heavy alcohol consumption
  • Hepatitis
  • Hematological abnormalities 1
• Contraindicated in active or chronic liver disease 1
• Warn patients about rare but permanent taste disturbance 1

Drug Interactions:

• Terbinafine has minimal interactions (only CYP2D6 substrates) 1
• Itraconazole has extensive CYP450 interactions 1

Follow-Up Strategy

• Re-evaluate at 3-6 months after treatment initiation 1
• If disease persists, consider:
  • Poor compliance
  • Resistant organism
  • Subungual dermatophytoma (requires partial nail removal) 2
  • Wrong diagnosis (reconfirm mycology)

Common Pitfalls to Avoid

1. Starting treatment without mycological confirmation - wastes resources and delays correct diagnosis 2, 3
2. Using topical therapy alone for moderate-severe disease - leads to treatment failure 1
3. Not checking baseline labs in at-risk patients - misses contraindications 1
4. Inadequate treatment duration - toenails require 12-16 weeks, not the 6 weeks used for fingernails 1

If Candida is Identified Instead

If mycology reveals Candida (not dermatophyte):

• Itraconazole 400 mg daily for 1 week per month × 3-4 pulses is most effective 2
• Candida toenail infections are much less common than dermatophyte infections 2

Expected Outcomes

With proper terbinafine treatment, expect:

• 70-80% cure rate for toenail infections 2
• 20-30% consistent failure rate even with optimal therapy 2
• 25% overall relapse rate (counsel on preventive measures) 4